Skip to main content
. 2025 Apr 22;167(1):112. doi: 10.1007/s00701-025-06520-9

Table 4.

Outcome parameters at 12 months

Follow up months (median, range) 28 (14–43)
Local control (%) 70.9%
Time to progression (median, CI95%) 13 months (9–21)
Intracranial failure (local + distant) (%) 41.9%

Distant intracranial failure only

(tumor bed controlled) (%)

12.9%
12 months overall survival (%) 80.6%

Radiation necrosis (%)

Asymptomatic

Symptomatic

12.9%

N = 6

N = 2